
physIQ delivers personalized medical insights through a proprietary AI platform that continuously monitors patients using wearable biosensors. This technology enables proactive detection of physiological changes, improving the safety and efficacy of new therapies while expediting clinical trials for pharmaceutical companies. With a focus on personalized clinical interventions, physIQ aims to enhance patient outcomes and reduce healthcare costs. The company operates in over 26 countries and has accumulated more than 4 million hours of on-body patient data, positioning itself as a leader in the healthcare and life sciences sectors.

physIQ delivers personalized medical insights through a proprietary AI platform that continuously monitors patients using wearable biosensors. This technology enables proactive detection of physiological changes, improving the safety and efficacy of new therapies while expediting clinical trials for pharmaceutical companies. With a focus on personalized clinical interventions, physIQ aims to enhance patient outcomes and reduce healthcare costs. The company operates in over 26 countries and has accumulated more than 4 million hours of on-body patient data, positioning itself as a leader in the healthcare and life sciences sectors.
What they do: AI platform that continuously monitors patients using wearable biosensors to detect physiological changes
Founded: 2011
Headquarters: Chicago, Illinois, United States
Scale: Operates in 26+ countries; >4 million hours of on-body patient data
Funding: Reported total funding ~ $26.4M; last funding event: Grant on 2020-01-29
Healthcare / clinical trials monitoring and personalized physiology analytics
2011
Biotechnology
Most recent funding event reported as a grant on Jan 29, 2020
Series B noted on July 25, 2017
“Purdue Foundry Investment Fund, Pioneer Healthcare Partners, 4490 Ventures, LionBird, Quark Venture, GF Securities, 20/20 HealthCare Partners”